Business
The industrial giant plans to retain a stake of almost 20% in GE Healthcare.
Cue received emergency use authorization for its at-home COVID-19 test in March and went public in September.
The new funding round brings the company's valuation to $4.6 billion.
The company said the latest round brings its total raise to $47 million.
The scheme is being run in partnership with government technology firm PUBLIC.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
This IPO comes roughly a year after the company closed a $25 million SPAC.
The company will cater to individuals with serious mental illness and severe depression.
Nanox also completed the acquisition of USARAD Holdings and its affiliated company, MDWEB.
Also: Pediatric sleep app Huckleberry raises $12.5 million, and illumigyn, maker of a platform for remote gynecological imaging, brings in $33 million.